What analysts say:
- Buy, sell, or hold?: Half of analysts think investors should stand pat on Amerigroup. Analysts like Amerigroup better than competitor WellCare Health Plans overall. Two out of 11 analysts rate WellCare Health Plans a buy compared to six out of 14 for Amerigroup. While analysts still rate the stock a hold, they are a little more optimistic about it compared to three months ago.
- Revenue forecasts: On average, analysts predict $1.57 billion in revenue this quarter. That would represent a rise of 5.4% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is earnings of $0.69 per share. Estimates range from $0.60 cents to $0.79.
What our community says:
CAPS All-Stars are solidly behind the stock, with 92.1% giving it an outperform rating. The community at large concurs with the All-Stars, with 90.1% assigning it a rating of outperform. Fools are keen on Amerigroup, though the message boards have been quiet lately, with only 81 posts in the past 30 days. Even with a robust four out of five stars, Amerigroup's CAPS rating falls a little short of the community's upbeat outlook.
Amerigroup's profit has risen year over year by an average of more than twofold over the past five quarters. Revenue has now gone up for three straight quarters.
We can help you keep tabs on your companies with My Watchlist, our free, personalized service. Add Amerigroup now.
Motley Fool newsletter services have recommended buying shares of AMERIGROUP. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.